[1]
Wazir, S.M., Paracha, M.M. and Khan, S.U. 2016. Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01%in vitiligo. Journal of Pakistan Association of Dermatologists. 20, 2 (Dec. 2016), 89–92.